Table 5.

The outcomes for neonates with hyperbilirubinemia based on maternal administration of anti-D immunoglobulin during pregnancy

Neonatal outcomes	Maternal anti-D immunoglobulin (n = 16)	Non-maternal anti-D immunoglobulin (n = 12)	P
OTNH (days)	2.0 (1.0, 2.0)	1.0 (1.0, 1.5)	0.119
RTNH (days)	1.0 (1.0, 1.5)	5.0 (1.5, 10.0)	0.002
Admitted to NICU, n (%)	3 (18.8)	4 (33.3)	0.659
Admission hemoglobin (g/L)	161.5 (152.0, 174.5)	149.0 (140.5, 162.5)	0.114
TB (umol/L)	201.0 ± 68.4	194.4 ± 53.0	0.784
ABO haemolysis, n (%)	1 (6.3)	1 (8.3)	> 0.999
NBT, n (%)	1 (6.3)	2 (16.7)	0.791
Rh haemolysis, n (%)	1 (6.7)	2 (16.7)	0.837

Mann–Whitney U tests were conducted for OTNH, RTNH, and Admission hemoglobin. TB was analyzed using an independent samples t-test, while the other variables were evaluated through chi-square tests or Fisher's exact tests

NBT Neonatal blood transfusion, OTNH Onset time of neonatal hyperbilirubinemia, RTNH Resolution time of neonatal hyperbilirubinemia, TB Total bilirubin